Skip to content

Clinical trials

Colonic Neoplasms trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Country / region: India Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20101
20111
20121
20204
20233
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed4
Recruiting4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asian Institute of Gastroenterology, India2
Aurigene Discovery Technologies Limited2
Natureceuticals Sdn Bhd2
Amgen1
GlaxoSmithKline1
Mast Therapeutics, Inc.1
NantCell, Inc.1
National Cancer Centre, Singapore1
National University Hospital, Singapore1
PVS Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms15
Rectal Neoplasms6
Colorectal Neoplasms5
Stomach Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Esophageal Neoplasms2
Kidney Neoplasms2
Neoplasm Metastasis2
Adenocarcinoma1
COVID-191

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.